Furthermore, a summary of recent research progress on eEF2K inhibitors for cancer chemotherapy is presented along with the detailed structure–activity relationships (SARs) and synthetic routes or natural sources of existing eEF2K inhibitors. Here, EEF2K is linked to cancer.